Two international retail brands extend their Invigor contracts

|

Published 11-MAY-2016 15:33 P.M.

|

1 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Two leading consumer electronics brands have re-signed with Invigor Group Limited (ASX:IVO).

The brands have signed a one year extension to existing contracts, highlighting the value proposition Invigor offers to both retailers and customers.

The contracts will see Invigor provide retail pricing intelligence.

Upon extending the major brand contracts, Invigor Chairman and CEO Mr Gary Cohen said, “It is very encouraging that major international brands continue to re-sign with us, further validating the value proposition that Insights Retail provides for brands and retailers across the Australian retail industry.”

There is further growth in the sales pipeline for Insights Retail, which is continuing its steady progress with major retailers.

Invigor’s Insights Retail platform is a competitive market intelligence platform across a range of product verticals for retailers and brands. The software used via the platform collects real-time data across online and offline prices, freight, consumer demand and marketing activity.

The Insights Retail platform analyses the data and offers clear next actions to clients to maximise revenue and margin.

The Insights Retail platform is a major part of Invigor’s complementary suite of big data products that aggregate, analyse and publish content for the benefit of businesses and consumers.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X